Dr. Liviu C Goia, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1 Main St, Warm Springs, MT 59756 Phone: 406-693-7447 Fax: 406-693-7069 |
Dr. Tatjana Caddell, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1main St, Warm Springs, MT 59756 Phone: 406-693-7142 Fax: 406-693-7069 |
Dr. Virginia L Hill, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1 Main St, Warm Springs, MT 59756 Phone: 406-693-7122 Fax: 406-693-7069 |
Dr. Myron K Meinhardt, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1 Main St, Warm Springs, MT 59756 Phone: 406-693-7000 Fax: 406-693-7063 |
Dr. Richard Lewis Holt, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 100 Garnet Way, Warm Springs, MT 59756 Phone: 406-560-8678 |
Dr. Daniel Jules Bemporad, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 100 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7000 Fax: 406-693-7069 |
Peter M Edwards, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 300 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7072 |
Dr. James Thomas Gray, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1 Main St, Warm Springs, MT 59756 Phone: 406-693-7051 Fax: 406-693-7063 |
John Muir, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2004 Hospital Way, Whitefish, MT 59937 Phone: 406-862-1030 Fax: 406-862-1556 |
Dr. Michael M Newman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 301 2nd St E, #1a, Whitefish, MT 59937 Phone: 406-862-0600 Fax: 406-862-1600 |
Dr. Mary Carol Sims, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 140 Weasel Creek Rd, Box 470126, Winston, MT 59647 Phone: 406-992-0195 Fax: 866-349-6549 |
News Archive
A study by J. William Harbour, M.D., associate director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues published today in Clinical Cancer Research details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.
Catalyst Pharmaceutical Partners, Inc. today reported that a team of neuroscientists at The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System (LIJ) has received a $1.2 million grant from the U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate addiction.
"Nearly a third of all countries affected by malaria are on course to eliminate the mosquito-borne disease over the next 10 years, the World Health Organization (WHO) said on Monday ... in a progress report published by the Roll Back Malaria (RBM) partnership at the start of an international Malaria Forum conference in Seattle," Reuters reports.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 1b clinical trial to determine the maximum tolerated dose and to evaluate preliminary efficacy of aldoxorubicin (formerly INNO-206) administered in combination with the commonly used chemotherapeutic agent doxorubicin in patients with advanced solid tumors who have failed other therapies.
› Verified 9 days ago